CHEST releases clinical practice guideline on antithrombotic therapy in arterial thrombosis and thromboembolism in COVID-19. June 29, 2023. |
5 мар. 2024 г. · Statement 11.0 (2021): In patients with an acute VTE (DVT of the leg or PE) we recommend apixaban, dabigatran, edoxaban, or rivaroxaban over VKA ... |
In patients with cerebral vein or venous sinus thrombosis, we recommend anticoagulation therapy for at least the treatment phase (first 3 mo) over no ... |
Disease: Second Update of the CHEST Guideline and Expert · Panel Report. Chest ... ESVS 2023 Management Guidelines on Antithrombotic Therapy for Vascular Diseases. |
23 нояб. 2022 г. · Key Recommendations · Stop VKAs ≥5 days prior to surgery, and restart VKAs <24 hours following surgery. · Do not provide routine heparin bridging ... |
1 окт. 2023 г. · ... CHEST Guidelines on Antithrombotic Therapy for Venous Thromboembolic Disease and Perioperative Management of Antithrombotic Therapy. |
recommendations, covering aspects of antithrombotic management of VTE from initial management through secondary prevention and risk reduction of postthrombotic ... |
2 мар. 2016 г. · Anticoagulation should be given for 3 months in patients with a first unprovoked VTE and a high risk of bleeding (Grade 1B), but should be ... |
Запросы по теме
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |